marizyme inc which trades on the otcqb filed for a stock offering and has applied for listing on the nasdaq capital market marizymes duragraft protects vascular grafts during bypass and other vascular surgeries in a filing the company said it expects the offering to price between 4 and 6 a share in december marizyme bought my health logic inc which provides labonchip technology